Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.5c04383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Hao Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Thioctic Acid, Nanoparticles, Sulfides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Despite the pleiotropic anticancer potential of the endogenous gasotransmitter hydrogen sulfide (H2S), achieving sustained and adequate intratumoral H2S supply remains a persistent challenge, hindering its advancement as a stand-alone therapeutic modality. Herein, we introduce cross-linked lipoic acid trisulfide nanoparticles (cLATN) that integrate both the H2S donor and transporter within a single precursor, wherein each unit theoretically yields one molecule of H2S, enabling stoichiometric H2S loading. cLATN effectively enter tumor cells via thiol-mediated uptake and are depolymerized by glutathione to trigger sufficient H2S release in tumor tissues for more than 48 h, far surpassing current H2S-based anticancer agents, which generally persist for only a few hours. Therapeutically, cLATN achieve an impressive tumor inhibition rate of 83% with favorable biocompatibility, far exceeding the clinical agent doxorubicin in both efficacy and safety. This work affirms its potential for cancer treatment, renewing interest in positioning H2S intervention as a stand-alone modality toward broader clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
ORCID-Profile: Gang Wang, Yangyang Cheng, Shiyong Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, H., Shao, Z., Wang, G., Cheng, Y., & Zhang, S. (2025). Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c04383
Vancouver
Guo H, Shao Z, Wang G, Cheng Y, Zhang S. Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c04383
BibTeX
@article{Guo2025,
author = {Guo, Hao and Shao, Zhong and Wang, Gang and Cheng, Yangyang and Zhang, Shiyong},
title = {Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.5c04383}
}
EUVIMED